1. Home
  2. GRFS vs SNV Comparison

GRFS vs SNV Comparison

Compare GRFS & SNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • SNV
  • Stock Information
  • Founded
  • GRFS 1940
  • SNV 1888
  • Country
  • GRFS Spain
  • SNV United States
  • Employees
  • GRFS N/A
  • SNV N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • SNV Major Banks
  • Sector
  • GRFS Health Care
  • SNV Finance
  • Exchange
  • GRFS Nasdaq
  • SNV Nasdaq
  • Market Cap
  • GRFS 6.6B
  • SNV 7.2B
  • IPO Year
  • GRFS 2006
  • SNV N/A
  • Fundamental
  • Price
  • GRFS $9.61
  • SNV $47.74
  • Analyst Decision
  • GRFS Hold
  • SNV Buy
  • Analyst Count
  • GRFS 1
  • SNV 22
  • Target Price
  • GRFS $10.30
  • SNV $58.77
  • AVG Volume (30 Days)
  • GRFS 550.4K
  • SNV 1.7M
  • Earning Date
  • GRFS 01-01-0001
  • SNV 10-15-2025
  • Dividend Yield
  • GRFS 1.47%
  • SNV 3.27%
  • EPS Growth
  • GRFS 132.60
  • SNV 218.56
  • EPS
  • GRFS 0.53
  • SNV 5.20
  • Revenue
  • GRFS $8,744,226,659.00
  • SNV $2,239,379,000.00
  • Revenue This Year
  • GRFS $5.61
  • SNV $29.99
  • Revenue Next Year
  • GRFS $6.70
  • SNV $5.32
  • P/E Ratio
  • GRFS $24.41
  • SNV $9.18
  • Revenue Growth
  • GRFS 9.32
  • SNV 32.95
  • 52 Week Low
  • GRFS $6.19
  • SNV $35.94
  • 52 Week High
  • GRFS $11.14
  • SNV $61.06
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 41.63
  • SNV 36.76
  • Support Level
  • GRFS $9.56
  • SNV $47.57
  • Resistance Level
  • GRFS $10.23
  • SNV $49.77
  • Average True Range (ATR)
  • GRFS 0.18
  • SNV 1.13
  • MACD
  • GRFS -0.01
  • SNV -0.25
  • Stochastic Oscillator
  • GRFS 11.85
  • SNV 3.32

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About SNV Synovus Financial Corp.

Synovus Financial Corp provides commercial and consumer banking in addition to a full suite of specialized products & services such as private banking, treasury management, wealth management, mortgage services, premium finance, asset-based lending, structured lending, capital markets, & international banking to clients through the wholly-owned subsidiary bank, Synovus Bank, and other offices in Alabama, Florida, Georgia, South Carolina, and Tennessee. It has four segments Wholesale Banking, Community Banking, Consumer Banking, and Financial Management Services, out of which the majority is from the Wholesale banking segment.

Share on Social Networks: